Synapse - Anti-Cancer Drugs

Anti-Cancer Drugs

Published by: Lippincott Williams & Wilkins

People

Fornier

Groups

Search Within

Results (1)

Export to EndNote / Excel

Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: Preliminary results of a feasibility-phase II study aimed at cardiotoxicity

Journal Article

Nisticò, C.; Bria, E.; Vaccaro, V.; Cuppone, F.; Fornier, M.; Sperduti, I.; Carpino, A.; Lzzo, F.; Tropea, F.; Cognetti, F.; more...
Anti-Cancer Drugs (2009)

Fulltext@MSK | Save

Anti-Cancer Drugs – authorized name for:

Name	ISSN / ISBN	Publisher
Anti-Cancer Drugs	09594973	Wolters Kluwer Health \| Lippincott Williams & Wilkins
Anti-Cancer Drugs	09594973	Wolters Kluwer Health \| Lippincott Williams & Wilkins
Anti-Cancer Drugs	0959-4973	Unknown
Anti-Cancer Drugs	09594973	Lippincott Williams & Wilkins
Anti-Cancer Drugs	0959-4973	Wolters Kluwer Health \| Lippincott Williams & Wilkins
Anti-Cancer Drugs	09594973	Unknown
Anti-Cancer Drugs	09594973	Wolters Kluwer Health \| Lippincott Williams & Wilkins
Anti-Cancer Drugs	09594973	Lippincott Williams & Wilkins
Anti-Cancer Drugs	0959-4973	Ovid Technologies, Inc.
Anti-Cancer Drugs	09594973	Lippincott Williams & Wilkins
Anti-Cancer Drugs	14735741	Unknown
Anti-Cancer Drugs	0959-4973	Rapid Science Publishers
Anti-Cancer Drugs	0959-4973	Lippincott Williams & Wilkins